Century Therapeutics is closing its Seattle operations as part of a 25% reduction in headcount and a shift in its priorities. The Philadelphia-based biotech startup launched a Seattle innovation ...
Farid Adrienne, the Chief Operations Officer of Century Therapeutics , Inc. (NASDAQ:IPSC), recently sold shares of the ...
PHILADELPHIA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in ...
26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative In vitro data showcases CNTY-101’s ability to induce CD19-specific cytolysis of B-cells and potential to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback